It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
-
Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained Japan Country Patent No. 7677628 [...] -
-
-
-
-
Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained Japan Country Patent No. 7677628 [...]
-
-
-
-
